Healthcare -
Biotechnology - NASDAQ - US
$ 15.12
1.96 %
$ 614 M
Market Cap
-88.88
P/E
KROS - OPERATING INCOME
Operating Income KROS - Keros Therapeutics, Inc.
-211 M
LAST VALUE
-35.52%
2 YEAR CAGR
-81.98%
5 YEAR CAGR
0.00%
10 YEAR CAGR